Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers

(2012) Lars Agréus et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori

(2010) Luigi Gatta et al.   Clinical Gastroenterology and Hepatology

Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations

(2010) Taraq A. Attumi et al.   Clinical Gastroenterology and Hepatology

The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology

(2009) Marcis Leja et al.   DIGESTIVE DISEASES AND SCIENCES

The Role of Serum Pepsinogen and Gastrin Test for the Detection of Gastric Cancer in Korea

(2008) Jung Mook Kang et al.   HELICOBACTER

Helicobacter pylorieradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer

(2007) Sergey I Pimanov et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY